Pfizer is currently offering a lucrative dividend yield of 6.3%, attracting attention from income-oriented investors. However, the company faces significant challenges stemming from weak growth prospects...
Pfizer has initiated legal proceedings against Metsera and Novo Nordisk in a Delaware court, following a recent bid by the Danish pharmaceutical company that surpasses Pfizer’s...
Pfizer is nearing an agreement for a significant acquisition of the weight-loss drugmaker Metsera, valued at approximately $7.3 billion. According to a report by the Financial...
